| Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis AG Singal, A Pillai, J Tiro PLoS medicine 11 (4), e1001624, 2014 | 818 | 2014 |
| Goals and targets for personalized therapy for HCC T Couri, A Pillai Hepatology international 13, 125-137, 2019 | 443 | 2019 |
| Probiotics for treatment of Clostridium difficile‐associated colitis in adults A Pillai, RL Nelson Cochrane Database of Systematic Reviews, 2008 | 430 | 2008 |
| Solid organ transplantation from hepatitis B virus–positive donors: consensus guidelines for recipient management S Huprikar, L Danziger-Isakov, J Ahn, S Naugler, E Blumberg, RK Avery, ... American Journal of Transplantation 15 (5), 1162-1172, 2015 | 232 | 2015 |
| Hepatitis B virus reactivation during successful treatment of hepatitis C virus with sofosbuvir and simeprevir JM Collins, KL Raphael, C Terry, EJ Cartwright, A Pillai, FA Anania, ... Clinical Infectious Diseases 61 (8), 1304-1306, 2015 | 207 | 2015 |
| Direct-acting antiviral therapy for hepatitis C virus infection is associated with increased survival in patients with a history of hepatocellular carcinoma AG Singal, NE Rich, N Mehta, AD Branch, A Pillai, M Hoteit, M Volk, ... Gastroenterology 157 (5), 1253-1263. e2, 2019 | 168 | 2019 |
| Direct-acting antiviral therapy not associated with recurrence of hepatocellular carcinoma in a multicenter North American cohort study AG Singal, NE Rich, N Mehta, A Branch, A Pillai, M Hoteit, M Volk, ... Gastroenterology 156 (6), 1683-1692. e1, 2019 | 161 | 2019 |
| Overview of immunosuppression in liver transplantation AA Pillai, J Levitsky World Journal of Gastroenterology: WJG 15 (34), 4225, 2009 | 160 | 2009 |
| Liver transplantation for hepatocellular carcinoma: management after the transplant EC Verna, YA Patel, A Aggarwal, AP Desai, C Frenette, AA Pillai, R Salgia, ... American Journal of Transplantation 20 (2), 333-347, 2020 | 119 | 2020 |
| Liver transplantation in the obese cirrhotic patient EK Spengler, JG O’Leary, HS Te, S Rogal, AA Pillai, A Al-Osaimi, A Desai, ... Transplantation 101 (10), 2288-2296, 2017 | 94 | 2017 |
| Liver transplantation for alcoholic hepatitis in the United States: excellent outcomes with profound temporal and geographic variation in frequency TG Cotter, B Sandıkçı, S Paul, A Gampa, J Wang, H Te, A Pillai, KG Reddy, ... American Journal of Transplantation 21 (3), 1039-1055, 2021 | 70 | 2021 |
| Non-alcoholic fatty liver disease: is bariatric surgery the answer? AA Pillai, ME Rinella Clinics in liver disease 13 (4), 689-710, 2009 | 69 | 2009 |
| Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection IA Hanouneh, AE Feldstein, R Lopez, L Yerian, A Pillai, CO Zein, NN Zein Clinical Gastroenterology and Hepatology 6 (5), 584-589, 2008 | 69 | 2008 |
| Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: evidence from an FDA pooled analysis of landmark clinical trials with validation … DJ Pinato, TU Marron, PS Mishra-Kalyani, Y Gong, G Wei, D Szafron, ... European Journal of Cancer 157, 140-152, 2021 | 54 | 2021 |
| The systemic inflammatory response identifies patients with adverse clinical outcome from immunotherapy in hepatocellular carcinoma A Muhammed, CAM Fulgenzi, S Dharmapuri, M Pinter, L Balcar, ... Cancers 14 (1), 186, 2021 | 52 | 2021 |
| Lower observed hepatocellular carcinoma incidence in chronic hepatitis B patients treated with entecavir: results of the ENUMERATE study J Ahn, JK Lim, HM Lee, AS Lok, M Nguyen, CQ Pan, A Mannalithara, H Te, ... Official journal of the American College of Gastroenterology| ACG 111 (9 …, 2016 | 50 | 2016 |
| Living donor liver transplantation in the United States: evolution of frequency, outcomes, center volumes, and factors associated with outcomes TG Cotter, M Minhem, J Wang, T Peeraphatdit, F Ayoub, A Pillai, ... Liver Transplantation 27 (7), 1019-1031, 2021 | 47 | 2021 |
| Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score … B Marinelli, E Kim, A D'Alessio, M Cedillo, I Sinha, N Debnath, M Kudo, ... Journal for immunotherapy of cancer 10 (6), 2022 | 42 | 2022 |
| Early antibiotic exposure is not detrimental to therapeutic effect from immunotherapy in hepatocellular carcinoma P Fessas, M Naeem, M Pinter, TU Marron, D Szafron, L Balcar, A Saeed, ... Liver Cancer 10 (6), 583-592, 2021 | 40 | 2021 |
| Recent advances in hepatocellular carcinoma treatment ND Parikh, A Pillai Clinical Gastroenterology and Hepatology 19 (10), 2020-2024, 2021 | 40 | 2021 |
